Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Summary

RATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well high-dose topotecan works as second-line therapy in treating patients with recurrent extensive-stage small cell lung cancer.

Timeline

Start

2004-04

Primary completion

2006-02

Completion

2006-02

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual”

Drugs

Indications